Use of primate IFN-gamma binding molecules

摘要

The present invention relates to the therapeutic use of molecules which bind and neutralize IFN-gamma in primates. More specifically, the present invention relates to the use of an anti-primate IFN-gamma antibody for preventing or treating diseases wherein IFN-gamma is pathogenic. The present invention further relates to a pharmaceutical composition comprising the anti-primate IFN-gamma antibody D9D10 for preventing or treating pathological reactions caused by IFN-gamma.